公开(公告)号：US20170185739A1

公开(公告)日：2017-06-29

申请号：US14980799

申请日：2015-12-28

Applicant: CERNER INNOVATION, INC.

Inventor： Patrizia Smouse Gomez ,  Jessica Alford ,  Krystal Cunningham ,  Ginger Querner ,  Justin Peterson ,  Yash Goyal ,  Hemin Merchant ,  Peng Li ,  Amy Stafford

IPC: G06F19/00 ,  A61B5/02

CPC classification number: A61B5/02042 ,  A61B5/01 ,  A61B5/021 ,  A61B5/024 ,  A61B5/0816 ,  A61B5/4343 ,  G01G19/00 ,  G01G19/44 ,  G16H10/60 ,  G16H50/30

Abstract: Methods and a system are provided for assessing postpartum hemorrhage risk and postpartum hemorrhage stages in a clinical setting. Generally, a clinician may indicate that the mass of several bloody items, indicated in type and quantity, is to be measured using a scale. The mass of bloody items is compared to the known unused dry mass of such items in order to accurately determine the quantitative blood loss (QBL) of a patient at the bedside. The cumulative QBL can be updated by weighing additional items. Based on the cumulative QBL, the patient's vital signs, and other factors, a corresponding hemorrhage stage is identified and communicated to the clinician. Recommendations specific to the hemorrhage stage are provided to a clinician. Some recommendations are selectable actions that trigger automatic placement of medical orders and notifications to relevant medical services, such as a blood bank or anesthesia.

公开(公告)号：US11185236B2

公开(公告)日：2021-11-30

申请号：US14980799

申请日：2015-12-28

Applicant: CERNER INNOVATION, INC.

Inventor： Patrizia Smouse Gomez ,  Jessica Alford ,  Krystal Cunningham ,  Ginger Querner ,  Justin Peterson ,  Yash Goyal ,  Hemin Merchant ,  Peng Li ,  Amy Stafford

IPC: A61B5/02 ,  G16H10/60 ,  G16H50/30 ,  G01G19/00 ,  A61B5/024 ,  A61B5/021 ,  A61B5/08 ,  A61B5/01 ,  A61B5/00

Abstract: Methods and a system are provided for assessing postpartum hemorrhage risk and postpartum hemorrhage stages in a clinical setting. Generally, a clinician may indicate that the mass of several bloody items, indicated in type and quantity, is to be measured using a scale. The mass of bloody items is compared to the known unused dry mass of such items in order to accurately determine the quantitative blood loss (QBL) of a patient at the bedside. The cumulative QBL can be updated by weighing additional items. Based on the cumulative QBL, the patient's vital signs, and other factors, a corresponding hemorrhage stage is identified and communicated to the clinician. Recommendations specific to the hemorrhage stage are provided to a clinician. Some recommendations are selectable actions that trigger automatic placement of medical orders and notifications to relevant medical services, such as a blood bank or anesthesia.

公开(公告)号：US12167905B2

公开(公告)日：2024-12-17

申请号：US17508541

申请日：2021-10-22

Applicant: CERNER INNOVATION, INC.

Inventor： Patrizia Smouse Gomez ,  Jessica Alford ,  Krystal Cunningham ,  Ginger Querner ,  Justin Peterson ,  Yash Goyal ,  Hemin Merchant ,  Peng Li ,  Amy Stafford

IPC: A61B5/02 ,  G01G19/00 ,  G16H10/60 ,  G16H50/30 ,  A61B5/00 ,  A61B5/01 ,  A61B5/021 ,  A61B5/024 ,  A61B5/08

Abstract: Methods and a system are provided for assessing postpartum hemorrhage risk and postpartum hemorrhage stages in a clinical setting. Generally, a clinician may indicate that the mass of several bloody items, indicated in type and quantity, is to be measured using a scale. The mass of bloody items is compared to the known unused dry mass of such items in order to accurately determine the quantitative blood loss (QBL) of a patient at the bedside. The cumulative QBL can be updated by weighing additional items. Based on the cumulative QBL, the patient's vital signs, and other factors, a corresponding hemorrhage stage is identified and communicated to the clinician. Recommendations specific to the hemorrhage stage are provided to a clinician. Some recommendations are selectable actions that trigger automatic placement of medical orders and notifications to relevant medical services, such as a blood bank or anesthesia.